Renalytix Plc announces that Ann Berman, non-executive director and chair of the audit and nomination committees, has resigned as a director of the Company for personal reasons effective immediately. The Company has begun a process to appoint a non-executive director and committee chair successors. The Board and the executive team would like to thank Ann for her dedication and contribution to the Company during her time as a non-executive director.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11 GBX | 0.00% |
|
-32.31% | -29.03% |
06-28 | ADRs Advance; Connect Biopharma Holdings Climbs 19% | DJ |
06-28 | EARNINGS AND TRADING: Thruvision loss widens but Polarean loss narrows | AN |
![Consensus](/images/consensus_flch.gif)
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-29.03% | 21.46M | |
-36.31% | 14.23B | |
-57.45% | 2.12B | |
+23.88% | 1.94B | |
-22.96% | 1.36B | |
+19.75% | 1.21B | |
-34.82% | 789M | |
+0.44% | 779M | |
-36.84% | 714M | |
-28.88% | 584M |
- Stock Market
- Equities
- RENX Stock
- News Renalytix Plc
- Renalytix plc Announces Ann Berman, Non-Executive Director and Chair of the Audit and Nomination Committees, Resigns as Director